Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor BlockersA Meta-Analysis

被引：0

作者：

Long Wang

Jian-wei Zhao

Bing Liu

Duo Shi

Zui Zou

Xue-yin Shi

机构：

[1] Second Military Medical University,Company 11

[2] Second Military Medical University,Company 17

[3] General Hospital of the Air Force of the Chinese People’s Liberation Army,Department of Stomatology

[4] Second Military Medical University,Department of Biochemical Pharmacy

[5] Second Military Medical University,Department of Anesthesiology, Changzheng Hospital

来源：

American Journal of Cardiovascular Drugs | 2012年 / 12卷 / 5期

关键词：

Systolic Blood Pressure; Diastolic Blood Pressure; Losartan; Random Effect Model; Valsartan;

D O I：

10.1007/BF03261842

中图分类号：

学科分类号：

摘要：

Objectives: Angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs]) have been shown to be effective and well tolerated in hypertensive patients. Olmesartan is the seventh angiotensin receptor blocker licensed by the US Food and Drug Administration. The aim of this meta-analysis was to determine the efficacy and tolerability of olmesartan medoxomil in comparison with other ARBs.

引用

页码：335 / 344

页数：9

共 50 条

[21] Cardiovascular Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Hemodialysis: A Meta-Analysis
Tai, Davina J.
Lim, Thomas W.
James, Matthew T.
Manns, Braden J.
Tonelli, Marcello
Hemmelgarn, Brenda R.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04): : 623 - 630
[22] Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers
Lagana, Stephen M.
Braunstein, Eric D.
Arguelles-Grande, Carolina
Bhagat, Govind
Green, Peter H. R.
Lebwohl, Benjamin
JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (01) : 29 - 32
[23] Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs (vol 16, pg S24, 2002)
Stumpe, KO
Ludwig, M
JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (12) : 865 - 865
[24] Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis
Salvador, Gabriel L. O.
Marmentini, Vinicius M.
Cosmo, Willian R.
Junior, Emilton L.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (18) : 1914 - 1924
[25] Meta-Analysis and Cost-Minimization Analysis of Allisartan and Other Angiotensin Receptor Blocking Antihypertensives for Hypertension
Chen, Mingyue
Lu, Xinying
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 152 - 160
[26] The Immediate Antihypertensive Effects of Aerobic Exercise: A Meta-Analysis
Corso, Lauren M. L.
MacDonald, Hayley V.
Johnson, Blair T.
Livingston, Jill
Jones, Alyssa
Pescatello, Linda S.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2017, 49 (05): : 841 - 842
[27] The Antihypertensive Effects of Aerobic Exercise Training: A Meta-Analysis
MacDonald, Hayley V.
Goldsby, TaShauna U.
Johnson, Blair T.
Huedo-Medina, Tania B.
Pescatello, Linda S.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 392 - 392
[28] Meta-analysis of angiotensin receptor blockers: Formulary considerations
Hilleman, D
Lenz, T
Wurdeman, R
JOURNAL OF HYPERTENSION, 2000, 18 : S159 - S159
[29] Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis
Wang, Yiwen
Zhou, Ran
Lu, Chi
Chen, Qing
Xu, Tongda
Li, Dongye
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (13):
[30] Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis
Debkumar Pal
Shampa Maji
Rituparna Maiti
High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 401 - 410

← 1 2 3 4 5 →